جستجوی استاد راهنمای دانشگاهی

• Respiratory Drug Delivery
• Pulmonary Drug Delivery
• Inhalation Aerosols
• +۵ مورد دیگر

Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.

Johan Ulrik Lindمشاهده پروفایل

دانشیار

• Additive Manufacturing
• Tissue Engineering
• Functional Materials
• +۶ مورد دیگر

Johan Ulrik Lind is an Associate Professor and Groupleader at the Department of Health Technology, Technical University of Denmark. His research focuses on cutting-edge biomedical engineering solutions including tissue engineering, bioprinting, and microphysiological systems. He actively contributes to additive manufacturing and functional materials development. Current Affiliation: Department of Health Technology, DTU Research Areas: 3D bioprinting, hydrogel technologies, microsystems engineering Expertise: UN Sustainable Development Goals for health and well-being Lind's work spans additive manufacturing for tissue engineering, functionalized biomaterials , and dynamic microphysiological systems . His recent publications highlight innovations in hydrogel formulation, bioink development, and particulate drug delivery systems. Notably, he holds a patent for transparent bioink formulation. He supervises multiple PhD projects including: micro-perfused bioartificial ovaries, embedded bioprinting of perfusable vasculatures, and 3D printed microsystems for tissue actuation. His research portfolio demonstrates strong interdisciplinary collaboration across engineering, biology, and pharmaceutical sciences.

Hao Louمشاهده پروفایل

استادیار

• Pharmaceutical Formulations
• Computational Modeling
• Molecular Dynamics
• +۵ مورد دیگر

Dr. Hao Lou is an Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas School of Pharmacy. His research integrates computational modeling and experimental approaches to advance drug formulation design, with emphasis on subcutaneous delivery systems for biologics and oral formulations. Research focuses on: Computational pharmaceutics using machine learning and molecular dynamics Subcutaneous delivery of monoclonal antibodies and protein therapeutics In vitro emulation of subcutaneous absorption (ESCAR system) Formulation optimization for cyclic peptides and biologics Protein stabilization and drying techniques Recent publications demonstrate novel applications of molecular dynamics simulations in predicting peptide properties, optimizing high-concentration protein formulations, and developing biorelevant dissolution methods. Work appears in pharmaceutical sciences journals covering formulation design and computational modeling. Developed innovative platforms including an Emulator of Subcutaneous Absorption and Release (ESCAR) and protein-hyaluronic acid precipitation techniques. Contributes to advancing dry powder processing for inhaled formulations.

Jennifer Fiegelمشاهده پروفایل

استاد

• Drug Delivery
• Aerosol Science
• Engineering Education
• +۳ مورد دیگر

Jennifer Fiegel serves as Professor and Chair of the Department of Chemical and Biomedical Engineering at the University of Missouri, leveraging over two decades of interdisciplinary expertise in aerosol science and educational innovation to advance therapeutic delivery systems and engineering pedagogy. Her academic foundation includes a BS from the University of Massachusetts at Amherst and a PhD from Johns Hopkins University. Dr. Fiegel's research program operates at the convergence of biomedical engineering and education science . Her drug delivery work pioneers inhalable/sprayable therapeutics targeting respiratory and skin infections through nanoparticle engineering and biofilm eradication strategies, while her education research develops metacognitive frameworks for ethical decision-making and faculty development. Key innovations include thermoreversible hydrogels for wound treatment and scaffolded 52-week initiatives transforming engineering culture. Recent publications reveal accelerating integration between her dual research domains, with nanoparticle delivery systems increasingly addressing complex biological barriers (mucus, biofilms) while educational frameworks evolve toward longitudinal cultural transformation in engineering education through choose-your-own-path simulations and TA empowerment programs. Dr. Fiegel directs collaborative research teams spanning engineering and health sciences, mentoring students through hands-on projects in aerosol characterization and educational intervention design. Her leadership includes developing comprehensive faculty development journeys focused on inclusive climate initiatives and evidence-based teaching practices. Her laboratories maintain dual focus: the Aerosol Drug Delivery Lab developing advanced formulations for pulmonary and topical applications, and the Engineering Education Innovation Lab creating metacognitive training modules and ethical decision-making simulations for engineering curricula.

• Food Microbiology
• Lactic Acid Bacteria Ecology
• Fermented Foods
• +۳ مورد دیگر

Prof. Benedetta Bottari is an Associate Professor at the Department of Food and Drug Science, University of Parma. She specializes in food microbiology, focusing on lactic acid bacteria, fermented foods, and microbial dynamics in dairy products like Parmigiano Reggiano cheese. Her research employs molecular techniques like PCR analysis and fluorescence microscopy to study microbial viability and biodiversity. Educational Background: PhD in Food Science and Technology (2006–2009), University of Parma MSc in Food Science and Technology (2004), University of Parma BSc in Agricultural Studies, Diploma from G. Marconi High School (1994–1999) Research Interests: Prof. Bottari’s work centers on microbial ecology in food systems, probiotic development, food safety, and the application of advanced molecular methods to study cheese microbiota. She has contributed to projects on prebiotic effects, UV treatment for microbial abatement, and the role of microbial communities in food quality. Grants & Projects: Co-led projects on Parmigiano Reggiano microbiota and probiotic strain selection Scientific coordination of EU-funded dairy science education initiatives Collaborations with industries like Tetra Pak and CIPACK for food safety solutions Teaching: She teaches courses in Food Microbiology, Probiotics, and Functional Foods across undergraduate and graduate programs in Food Engineering, Gastronomy, and Nutrition. Labs & Teams: Her research group focuses on food microbiology, collaborating with institutions like SIMTREA and the Parmigiano Reggiano Consortium to advance food technology and safety.

• Computational Fluid Dynamics
• Fluid Dynamics
• Heat Transfer
• +۴ مورد دیگر

David Fletcher is an Adjunct Professor at the University of Sydney's School of Chemical and Biomolecular Engineering. He holds a BSc and PhD in Mathematics from the University of Exeter (UK) and a Habilitation à Diriger des Recherches (HDR) from the Institut National Polytechnique de Toulouse (France). His expertise spans computational fluid dynamics (CFD), fluid-structure interaction (FSI), and multiphase flow modeling with applications in biomedical systems, pharmaceutical inhalers, and chemical engineering. Education: BSc Mathematics, University of Exeter (1979) PhD, University of Exeter (1982) HDR in Chemical Engineering, Université de Toulouse (2002) Research Interests: Coupled systems simulation (e.g., combustion, micro-flows, biomedical applications) CFD education and software development Bioinspired heart valve design for pediatric use PFAS degradation via CFD-optimized reactors Key Projects: Polymeric heart valve design collaboration with Cincinnati Children’s Hospital CFD modeling of pharmaceutical inhalers with Macquarie University Bubble column optimization for energy-efficient bioreactors Awards: Recognized among the Top 2% of global researchers in 2019, 2021, and 2023 (PLOS Biology ranking). International Collaborations: France (INP Toulouse), Malaysia (Universiti Malaysia Pahang), UK (University of Birmingham), USA (Ann & Robert H. Lurie Children’s Hospital). Students: Supervised PhD graduates now in academia (China, Saudi Arabia) and industry (Australia, India).

Julio Soriaمشاهده پروفایل

استاد

• Fluid Mechanics
• Turbulence
• Turbulent Shear Flows
• +۱۲ مورد دیگر

Julio Soria is a Professor in the Department of Mechanical & Aerospace Engineering at Monash University, where he also holds a leadership role at the Victorian Heart Institute (VHI). He has been a core academic staff member since 1993 and was promoted to full Professor in 2000. He founded and directs the Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), a key research hub in fluid dynamics. PhD in Mechanical Engineering, University of Western Australia (1989) B.E. (1st Class Honours), University of Western Australia (1983) Postdoctoral Fellowships: CSIRO (1989–1990), Stanford University & NASA Ames Research Center (1990–1991) His research spans Fluid Mechanics , with emphasis on turbulent flows , boundary layers , supersonic jets , and optical measurement techniques like PIV and tomographic methods. Recently, he has integrated scientific machine learning and physics-informed neural networks into fluid dynamics research. His work bridges engineering and biomedical applications, including drug delivery and cardiovascular flows. The most recent publications highlight his work in biomedical fluid dynamics (e.g., sperm motility), inhaler design using CFD and PIV, and advanced 4D imaging techniques. These reflect broad expertise in both experimental and computational methods. His scientific honors include: Fellow, Australasian Fluid Mechanics Society Associate Fellow, American Institute of Aeronautics and Astronautics (AIAA) Member, American Physical Society Member, EUROMECH He serves as Associate Editor of Theoretical and Computational Fluid Mechanics and on editorial boards of Experiments in Fluids and Experimental and Thermal Fluid Science . He leads multiple active research projects in turbulence, flow control, and biomedical applications, and is actively mentoring PhD students. He is also a key investigator in interdisciplinary collaborations involving medical devices and industrial fluid systems. Julio Soria leads the Laboratory for Turbulence Research in Aerospace & Combustion (LTRAC), established in 1994, which conducts cutting-edge research in experimental and computational fluid dynamics, with applications in aerospace, energy, and health.

• Dry Powder Inhalers
• Pulmonary Drug Delivery
• Cystic Fibrosis
• +۶ مورد دیگر

Paul Hagedoorn is a Researcher at the Faculty of Science and Engineering , University of Groningen, specializing in Pharmaceutical Technology and Biopharmacy . His work focuses on inhalation technology, pulmonary drug delivery, and medical device development. Expertise in Dry Powder Inhalers and Smart Inhalers Active in Cystic Fibrosis , Parkinson's Disease , and Asthma Treatment Published extensively on Pharmacokinetics and Digital Health applications Recent research includes clinical trials on inhaled Tobramycin for cystic fibrosis and Levodopa formulations for Parkinson's disease. He also explores digital monitoring tools for asthma management. His collaborations span respiratory medicine, neurology, and pharmaceutical engineering, with key contributions to Dry Powder Formulation and Patient-Centered Inhalation Technologies . Contact: p.hagedoorn@rug.nl

Ruggero Bettiniمشاهده پروفایل

استاد

• Pharmaceutical Technology
• Controlled Drug Delivery
• Solid-State Chemistry
• +۵ مورد دیگر

Prof. Ruggero Bettini is a Full Professor of Pharmaceutical Technology at the Department of Food and Drug Sciences, University of Parma. He is a member of the Board of Directors and has held significant roles including Director of the Interdepartmental Center for Innovation in Health Products (Biopharmanet-Tec) and President of the Spin-off Committee. He founded PumeStars srl, Anemos Therapeutics srl, and co-founded M3datek srl. Education: PhD in Pharmaceutical Chemistry and Technology (University of Pavia, 1994); MS in Pharmacy (University of Parma, 1991) Academic Leadership: Coordinator of Biopharmaceutics-Pharmacokinetics PhD program (2015-2016); Active in European University Consortium for Pharmaceutical Sciences (ULLA) since 2015 Research Focus: Solid dosage forms for controlled drug delivery, nasal/pulmonary administration, particle engineering, solid-state chemistry, and pharmaceutical production processes. His research spans respiratory drug delivery systems, biomaterials for regenerative medicine, and pharmaceutical formulation optimization. Recent publications highlight anti-inflammatory microparticles, radiopharmaceutical validation methods, and novel approaches to pulmonary delivery of antivirals and immunomodulators. Scientific achievements include: 1999: J. Heller Journal of Controlled Release Outstanding Paper Award 2000: First Eurand Award for Oral Drug Delivery Research 2014: Listed in 'Who is Who in Thermal Analysis and Calorimetry' 2016: AAPS Fellow 2019: AIMBE Fellow He serves as Associate Editor of Pharmaceutics and editorial board member of multiple journals. His teaching portfolio includes courses on formulation development and pharmaceutical technology at both undergraduate and graduate levels.

Omar Usmaniمشاهده پروفایل

استاد

• Inhaled Drug Delivery
• Small Airways Physiology
• Lung Imaging
• +۵ مورد دیگر

Professor Omar Usmani is a Professor of Respiratory Medicine at the National Heart and Lung Institute (NHLI), Imperial College London, and Consultant Physician at the Royal Brompton Hospital. He leads the Clinical Research Group within NHLI's Airway Disease Section and is Co-Director of Imperial's Network of Excellence in Aerosols and Health. His expertise spans inhaled drug delivery, small airways physiology, and tele-monitoring. He holds leadership roles in global societies like ISAM (President-elect) and ERS (former Head of Assembly 5). Key awards include the Thomas T. Mercer Award (2015) and FERS (2019). Education: MB BS (King's College London), PhD (Imperial College London), CASLAT (Imperial College). His research has secured grants including EU Horizon 2020 (myaircoach) and FDA funding ($2.3M). Teaching roles include leading Imperial's MBBS Phase 1 programme and mentoring PhD/MSc students. Public outreach includes STEM initiatives for underprivileged London schoolchildren and media appearances on BBC's Horizon and Fake Britain. Research focuses on optimizing inhaled therapies, aerosol science, and small airways dysfunction. Articles highlight innovations in drug delivery, telehealth, and inhaler adherence. He advises pharmaceutical companies and regulatory bodies like the FDA on inhaler design and clinical outcomes.

• Nanomedicine
• Drug Delivery Systems
• Pharmaceutical Technology
• +۴ مورد دیگر

Noemi Stefanía Csaba is a Professor at the University of Santiago de Compostela, affiliated with the Department of Pharmacology, Pharmacy and Pharmaceutical Technology within the Faculty of Pharmacy. She is also part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Her research focuses on nanotechnologies applied to drug delivery systems, particularly in the development of gene therapy carriers, vaccines, and targeted therapies for cancer and infectious diseases. She earned her PhD in 2005 with a thesis on genetic vaccine delivery systems under the supervision of Dr. María José Alonso Fernández and Dr. Alejandro Sánchez Barreiro. Her research interests encompass nanomedicine, biomaterials engineering, and mucosal drug delivery. She has pioneered studies on protamine nanocapsules, chitosan-based systems, and polyphosphazene derivatives for targeted drug delivery. Her work addresses challenges in overcoming biological barriers (e.g., nasal-to-brain, pulmonary, intestinal) and enhancing therapeutic efficacy through nanoparticle design. Notable contributions include the development of semisynthetic pneumococcal nanovaccines, hybrid peptide-polymer platforms for cancer immunotherapy, and lymphatic-targeted anticancer nanocarriers. Her articles highlight advancements in gene delivery for glioblastoma, ocular tumor treatment, and macrophage-targeted pulmonary therapies. While no specific awards are listed, her prolific publication record (spanning 2002–2025) reflects sustained innovation in pharmaceutical nanotechnology. She collaborates widely on projects integrating biomaterials, molecular medicine, and translational drug delivery systems. Her lab (NANOBIOFAR research group) focuses on translational nanomedicine, emphasizing practical applications such as ready-to-use dry powders for pulmonary delivery and plant-derived sporopollenin microcapsules for drug encapsulation. Current work includes optimizing nanoparticle stability, improving vaccine adjuvants, and addressing barriers in intestinal and transmucosal drug absorption.

• Materials Science
• Chemical Engineering
• Nanotechnology
• +۳ مورد دیگر

Emily Cranston is an Adjunct Associate Professor in the Department of Chemical Engineering at McMaster University , where she holds the Canada Research Chair in Bio-Based Nanomaterials . Her research focuses on advanced applications of cellulose nanocrystals (CNCs) in polymer composites, biomedical materials, and sustainable technologies. Research Interests Cellulose nanocrystal surface modification Mechanical properties of bio-based composites Injectable hydrogels for tissue engineering Green adhesive systems Nanocellulose in energy storage devices Biodegradable foam insulation materials Recent Work Trends 2024-2025 studies on water-based hydrophobization strategies Investigations into CNC-lateX interactions for coatings Advancements in vaccine delivery systems using nanocellulose Structural analysis of wood particles for insulative foams Awards Canada Research Chair in Bio-Based Nanomaterials Teaching Instructor for CHEMENG 2G03: Problem Solving and Technical Communication (2018)

• Aerosol Technology
• Sustainable Materials
• Nanoparticle Synthesis
• +۳ مورد دیگر

Anna Lähde is a Professor in Aerosol Technology at the Department of Environmental and Biological Sciences, University of Eastern Finland. She leads the Sustainable Materials Group at the Fine Particle and Aerosol Technology Laboratory . Her work focuses on the synthesis and characterization of sustainable nano- and microparticles for clean energy and environmental applications. Academy of Finland Research Fellow (2017-2022) Specializes in graphene, carbon nanostructures, and metal oxides via aerosol processes Key methods: induction annealing, chemical vapor synthesis, spray pyrolysis Her research spans Li-ion battery materials , water treatment nanocomposites , and toxicological analysis of airborne particles . She has published extensively on carbon-based anode materials , photocatalytic systems , and environmental applications of aerosol technology . Recent work includes CO2 adsorption catalysts and biomass-derived graphene . She has received recognition through the Academy of Finland Fellowship and contributes to circular economy projects like EKOAKKU.

Hendrik Versteegمشاهده پروفایل

مدرس ارشد

• Fluid Mechanics
• Biomedical Engineering
• Biomimetics
• +۶ مورد دیگر

Dr. Hendrik Versteeg is a Senior Lecturer in Fluid Mechanics at the Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University. He has been affiliated with the institution since 1988, following prior research roles at BHRA Fluid Engineering and Cranfield Institute of Technology. His research focuses on biomimetic engineering, porous materials for biomedical applications, and pharmaceutical aerosol technology, particularly in pressurized metered dose inhalers (pMDIs). He leads the Multifunctional Materials Manufacturing (MMM) Lab and collaborates with industry partners like EPSRC and the Wolfson Bursary Scheme. Key research areas include additive manufacturing for medical devices, osteoblastic maturation in titanium scaffolds, and the thermodynamic modeling of aerosol generation. Notable projects include the design of trabecular-like porous scaffolds for orthopedic implants and the study of bimodal pore size distributions for enhanced cellular growth. His work integrates computational fluid dynamics (CFD) and experimental methods to advance medical device innovation and tissue engineering. Dr. Versteeg advises students such as Mudassar Khalil and has mentored alumni Dr. Mattia Norrito and Dr. Fares Almushref. His research has been supported by grants from EPSRC and industry collaborations. He maintains ties with global institutions like McGill University’s Department of Bioengineering, where he explores biomimetic structures in natural materials.

Benjamin Jungمشاهده پروفایل

استاد

• Strategic Management
• Business Model Innovation
• Automotive Industry Transformation
• +۴ مورد دیگر

Prof. Dr. Benjamin Jung is a Professor of Industrial Engineering, specializing in Business Management at the Osnabrück University of Applied Sciences. He holds a doctoral degree (Dr. rer. pol.) from the University of Duisburg-Essen and has extensive industry experience as Managing Director at Heitkamp & Thumann Group. His research focuses on strategic decisions in radical technological transitions, particularly in the automotive and healthcare sectors. He leads the Faculty of Management, Culture and Technology and serves as the Startup Coordinator. Education & Career: PhD from University of Duisburg-Essen (2010-2014), RWTH Aachen (Industrial Engineering degree with international studies in Lille). Industry roles include Managing Director at H&T Tool Design and H&T Production Technology (2019-2021), Program Manager for Connected Devices at H&T Presspart (2016-2019), and Executive Education at ESMT Berlin, Darden School of Business, and CKGSB. Research Focus: Strategic decisions in corporate boundary decisions during technological shifts, portfolio models for corporate strategy, and strategy implementation practices. Key areas include automotive industry transformation towards electromobility and connected medical device innovations in respiratory care. Publications: Over 20 peer-reviewed articles and patents focusing on automotive business models, NPV traps in innovation portfolios, and connected inhaler technology. Recent work analyzes EV sales impact on automaker valuations and strategic challenges in mobility transitions. Roles: Professor at Osnabrück University (since 2022), Startup Coordinator for Faculty, Adjunct Lecturer at Professional School. Previously: Assistant to Managing Board at Heitkamp & Thumann Group (2014-2016), Research Assistant at Duisburg-Essen University's Automotive Management Chair (2010-2013).